002907 华森制药
已收盘 11-26 15:00:00
资讯
新帖
简况
华森制药11月25日现4笔大宗交易 成交金额967.03万元
新浪证券-红岸工作室 · 11-25 17:00
华森制药11月25日现4笔大宗交易 成交金额967.03万元
11月25日华森制药现4笔折价10.42%的大宗交易 合计成交967.03万元
证券之星 · 11-25 16:48
11月25日华森制药现4笔折价10.42%的大宗交易 合计成交967.03万元
华森制药:阿戈美拉汀原料药获批上市
上海 · 11-21
华森制药:阿戈美拉汀原料药获批上市
华森制药(002907.SZ)获得阿戈美拉汀化学原料药上市申请批准通知书
智通财经 · 11-21
华森制药(002907.SZ)获得阿戈美拉汀化学原料药上市申请批准通知书
华森制药最新公告:获得阿戈美拉汀化学原料药上市申请批准通知书
证券之星 · 11-21
华森制药最新公告:获得阿戈美拉汀化学原料药上市申请批准通知书
11月20日华森制药现7笔折价11.79%的大宗交易 合计成交2911.07万元
证券之星 · 11-20
11月20日华森制药现7笔折价11.79%的大宗交易 合计成交2911.07万元
华森制药最新公告:公司药品小儿咽扁颗粒通过GMP符合性检查
证券之星 · 11-15
华森制药最新公告:公司药品小儿咽扁颗粒通过GMP符合性检查
华森制药(002907.SZ)通过药品GMP符合性检查
智通财经 · 11-15
华森制药(002907.SZ)通过药品GMP符合性检查
华森制药:11月13日召开分析师会议,重庆环保产业私募股权投资基金管理有限公司、钟峥嵘,商思为,周康参与
证券之星 · 11-14
华森制药:11月13日召开分析师会议,重庆环保产业私募股权投资基金管理有限公司、钟峥嵘,商思为,周康参与
华森制药:11月11日进行路演,泰康基金参与
证券之星 · 11-12
华森制药:11月11日进行路演,泰康基金参与
华森制药11月12日现3笔大宗交易 成交金额706.49万元
新浪证券-红岸工作室 · 11-12
华森制药11月12日现3笔大宗交易 成交金额706.49万元
11月12日华森制药现3笔大宗交易 机构净买入401.28万元
证券之星 · 11-12
11月12日华森制药现3笔大宗交易 机构净买入401.28万元
华森制药:11月6日召开业绩说明会,投资者参与
证券之星 · 11-06
华森制药:11月6日召开业绩说明会,投资者参与
图解华森制药三季报:第三季度单季净利润同比增701.72%
证券之星 · 10-28
图解华森制药三季报:第三季度单季净利润同比增701.72%
华森制药(002907.SZ)发布前三季度业绩,净利润7457.68万元,同比增长66.56%
智通财经 · 10-28
华森制药(002907.SZ)发布前三季度业绩,净利润7457.68万元,同比增长66.56%
华森制药(002907.SZ)控股股东拟减持不超3%股份
智通财经网 · 10-21
华森制药(002907.SZ)控股股东拟减持不超3%股份
华森制药最新公告:控股股东成都地建计划减持不超过公司总股本的3%
证券之星 · 10-21
华森制药最新公告:控股股东成都地建计划减持不超过公司总股本的3%
华森制药:控股股东拟减持不超3%股份
美港电讯 · 10-21
华森制药:控股股东拟减持不超3%股份
华森制药最新公告:收到药品再注册批准通知书
证券之星 · 10-16
华森制药最新公告:收到药品再注册批准通知书
华森制药(002907.SZ)收到曲克芦丁注射液药品再注册批准通知书
智通财经 · 10-16
华森制药(002907.SZ)收到曲克芦丁注射液药品再注册批准通知书
加载更多
公司概况
公司名称:
重庆华森制药股份有限公司
所属行业:
医药制造业
上市日期:
2017-10-20
主营业务:
重庆华森制药股份有限公司主要从事中成药、化学药的研发、生产和销售,拥有片剂、颗粒剂、胶囊剂、软胶囊剂、散剂、粉针剂、冻干粉针剂、原料药、中药提取、小容量注射剂等11条生产线。公司荣获“新中国成立70周年医药行业标杆企业”荣誉称号,2019中国医药工业100强,2018年度中国中药企业TOP100,2018年度中国医药行业成长50强,中华中医药学会科学技术奖一等奖项和荣誉,并在中国非处方药物协会举办的2019年度中国非处方药生产企业排名活动中取得第58位的佳绩。公司获得由国家工业和信息化部评为“2021年国家技术创新示范企业”、由中国合格评定国家认可委员会颁发“中国合格评定国家认可委员会试验室证书”,由中华全国工商联合会、中国人力资源和社会保障部、中华全国总工会评为“全国就业与社会保障先进民营企业”、由重庆市工商业联合会评为“重庆民营企业科技创新指数100强”及“重庆制造业民营企业100强”。
发行价格:
4.53
{"stockData":{"symbol":"002907","market":"SZ","secType":"STK","nameCN":"华森制药","latestPrice":13.64,"timestamp":1732604589000,"preClose":13.63,"halted":0,"volume":2590171,"delay":0,"floatShares":309000000,"shares":418000000,"eps":0.1497,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"11-26 15:00:00","open":13.65,"high":13.91,"low":13.57,"amount":35624900,"amplitude":0.0249,"askPrice":13.65,"askSize":40,"bidPrice":13.64,"bidSize":1,"shortable":0,"etf":0,"ttmEps":0.1497,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732671000000},"adr":0,"adjPreClose":13.63,"symbolType":"stock","openAndCloseTimeList":[[1732584600000,1732591800000],[1732597200000,1732604400000]],"highLimit":14.99,"lowLimit":12.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":417596314,"pbRate":3.43,"roa":"--","roe":"4.53%","epsLYR":0.0783,"committee":0.67,"marketValue":5696000000,"floatMarketCap":4213000000,"peRate":91.115564,"changeRate":0.0007,"turnoverRate":0.0084,"status":0},"requestUrl":"/m/hq/s/002907","defaultTab":"news","newsList":[{"id":"2486470868","title":"华森制药11月25日现4笔大宗交易 成交金额967.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486470868","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486470868?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:00","pubTimestamp":1732525200,"startTime":"0","endTime":"0","summary":" 11月25日,华森制药收涨1.04%,收盘价为13.63元,发生4笔大宗交易,合计成交量79.2万股,成交金额967.03万元。 第4笔成交价格为12.21元,成交17.00万股,成交金额207.57万元,溢价率为-10.42%,买方营业部为机构专用,卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。 进一步统计,近3个月内该股累计发生16笔大宗交易,合计成交金额为4584.59万元。该股近5个交易日累计上涨2.17%,主力资金合计净流出861.09万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-25/doc-incxhkcn8246692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2486777436","title":"11月25日华森制药现4笔折价10.42%的大宗交易 合计成交967.03万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486777436","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486777436?lang=zh_cn&edition=full","pubTime":"2024-11-25 16:48","pubTimestamp":1732524493,"startTime":"0","endTime":"0","summary":"证券之星消息,11月25日华森制药发生大宗交易,交易数据如下:近三个月该股共发生16笔大宗交易,合计成交3.68万手,折价成交16笔。该股近期无解禁股上市。截至2024年11月25日收盘,华森制药(002907)报收于13.63元,上涨1.04%,换手率0.83%,成交量2.55万手,成交额3463.11万元。该股近半年内有股东持股变动,合计净减持53.4万股,股东增减持明细如下表:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112500021014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2485647594","title":"华森制药:阿戈美拉汀原料药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2485647594","media":"上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485647594?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:16","pubTimestamp":1732187760,"startTime":"0","endTime":"0","summary":"华森制药公告,公司于近日收到国家药品监督管理局核准签发的关于阿戈美拉汀的《化学原料药上市申请批准通知书》。阿戈美拉汀原料药用于公司生产药品阿戈美拉汀片,该药品是一种新型抗抑郁药物。 \n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-21/doc-incwvpzk1350437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2485457575","title":"华森制药(002907.SZ)获得阿戈美拉汀化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485457575","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485457575?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:34","pubTimestamp":1732181659,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华森制药(002907.SZ)发布公告,公司于近日收到国家药品监督管理局核准签发的关于阿戈美拉汀的《化学原料药上市申请批准通知书》。阿戈美拉汀:原料药,用于生产阿戈美拉汀片。该药品是一种新型抗抑郁药物,其作用机制突破了传统单胺类递质系统,通过激活褪黑素受体(MT1和MT2)以及拮抗5-HT2C受体,在发挥抗抑郁疗效的同时兼具调节生物节律的作用。本次《化学原料药上市申请批准通知书》的取得,表明该原料药已符合国家相关药品审评技术标准,不仅可以有效保障原料药质量及供应,而且自产原料药可以有效控制生产成本,使本品在集采中更具优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214086.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2485579354","title":"华森制药最新公告:获得阿戈美拉汀化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485579354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485579354?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:31","pubTimestamp":1732181495,"startTime":"0","endTime":"0","summary":"华森制药公告,公司于近日收到国家药监局核准签发的关于阿戈美拉汀的《化学原料药上市申请批准通知书》。该原料药已符合国家相关药品审评技术标准,不仅可以有效保障原料药质量及供应,而且自产原料药可以有效控制生产成本,使本品在集采中更具优势。阿戈美拉汀原料药用于公司生产药品阿戈美拉汀片,该药品是一种新型抗抑郁药物,2023年整体市场份额为9.24亿元。本次获得《化学原料药上市申请批准通知书》短期内不会对公司业绩产生重大影响。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100029374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2484169660","title":"11月20日华森制药现7笔折价11.79%的大宗交易 合计成交2911.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484169660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484169660?lang=zh_cn&edition=full","pubTime":"2024-11-20 16:46","pubTimestamp":1732092412,"startTime":"0","endTime":"0","summary":"证券之星消息,11月20日华森制药发生大宗交易,交易数据如下:近三个月该股共发生12笔大宗交易,合计成交2.88万手,折价成交12笔。该股近期无解禁股上市。截至2024年11月20日收盘,华森制药(002907)报收于14.0元,上涨2.56%,换手率0.97%,成交量3.0万手,成交额4173.74万元。该股近半年内有股东持股变动,合计净减持53.4万股,股东增减持明细如下表:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000028108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2483346777","title":"华森制药最新公告:公司药品小儿咽扁颗粒通过GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346777?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:53","pubTimestamp":1731660818,"startTime":"0","endTime":"0","summary":"华森制药公告,公司于近日收到重庆市药品监督管理局颁发的《药品GMP符合性检查告知书》(编号:渝GMP20240073),药品小儿咽扁颗粒通过上市前药品GMP符合性检查。该药品功能主治为清热利咽,解毒止痛,用于小儿肺卫热盛所致的喉痹、乳蛾,症见咽喉肿痛、咳嗽痰盛、口舌糜烂;急性咽炎、急性扁桃腺炎见上述证候者。本次取得《药品GMP符合性检查告知书》为《药品生产许可证》生产场地变更的关联事项。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500026793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2483346568","title":"华森制药(002907.SZ)通过药品GMP符合性检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2483346568","media":"智通财经","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483346568?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:42","pubTimestamp":1731660177,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华森制药(002907.SZ)公告,公司近日收到重庆市药品监督管理局颁发的《药品GMP符合性检查告知书》,相关药品名称为:小儿咽扁颗粒。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2483822960","title":"华森制药:11月13日召开分析师会议,重庆环保产业私募股权投资基金管理有限公司、钟峥嵘,商思为,周康参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2483822960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483822960?lang=zh_cn&edition=full","pubTime":"2024-11-14 18:34","pubTimestamp":1731580488,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月14日华森制药发布公告称公司于2024年11月13日召开分析师会议,重庆环保产业私募股权投资基金管理有限公司、钟峥嵘,商思为,周康参与。仿制药及中成药的开发是公司营收和利润持续增长以及现金流的保障,通过持续加强研发投入和不断完善研发团队建设,目前公司“三三三”研发战略已经成型。目前仿制药在研管线研发目标是参与首轮集采,新产品的不断上市会为公司带来新的营收。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400030878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2482771864","title":"华森制药:11月11日进行路演,泰康基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2482771864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482771864?lang=zh_cn&edition=full","pubTime":"2024-11-12 18:35","pubTimestamp":1731407725,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月12日华森制药发布公告称公司于2024年11月11日进行路演,泰康基金经理 傅洪哲参与。目前仿制药在研管线研发目标是参与首轮集采,新产品的不断上市会为公司带来新的营收。华森制药2024年三季报显示,公司主营收入6.14亿元,同比上升19.21%;归母净利润7457.68万元,同比上升66.56%;扣非净利润6002.33万元,同","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200030835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2482720292","title":"华森制药11月12日现3笔大宗交易 成交金额706.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482720292","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482720292?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:00","pubTimestamp":1731402000,"startTime":"0","endTime":"0","summary":" 11月12日,华森制药收涨0.77%,收盘价为14.38元,发生3笔大宗交易,合计成交量53.4万股,成交金额706.49万元。 第1笔成交价格为13.20元,成交15.20万股,成交金额200.64万元,溢价率为-8.21%,买方营业部为机构专用,卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。 进一步统计,近3个月内该股累计发生3笔大宗交易,合计成交金额为706.49万元。该股近5个交易日累计上涨3.23%,主力资金合计净流入154.22万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-12/doc-incvuxsf9536864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2482727227","title":"11月12日华森制药现3笔大宗交易 机构净买入401.28万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482727227","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482727227?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:46","pubTimestamp":1731401217,"startTime":"0","endTime":"0","summary":"证券之星消息,11月12日华森制药发生大宗交易,交易数据如下:近三个月该股共发生3笔大宗交易,合计成交5340.0手,折价成交3笔。该股近期无解禁股上市。截至2024年11月12日收盘,华森制药(002907)报收于14.38元,上涨0.77%,换手率2.65%,成交量8.19万手,成交额1.19亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200026806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2481550672","title":"华森制药:11月6日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2481550672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481550672?lang=zh_cn&edition=full","pubTime":"2024-11-06 19:34","pubTimestamp":1730892862,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年11月6日华森制药发布公告称公司于2024年11月6日召开业绩说明会。相信未来会创造更好的业绩,为投资者带来报。截至三季度末,公司电商平台销售额已突破 1100 万元。华森制药2024年三季报显示,公司主营收入6.14亿元,同比上升19.21%;归母净利润7457.68万元,同比上升66.56%;扣非净利润6002.33万元,同比上升60.53%;其中2024年第三季度,公司单季度主营收入1.96亿元,同比上升26.85%;单季度归母净利润2736.19万元,同比上升701.72%;单季度扣非净利润18","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600033314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2478171960","title":"图解华森制药三季报:第三季度单季净利润同比增701.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478171960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478171960?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:21","pubTimestamp":1730107283,"startTime":"0","endTime":"0","summary":"证券之星消息,华森制药2024年三季报显示,公司主营收入6.14亿元,同比上升19.21%;归母净利润7457.68万元,同比上升66.56%;扣非净利润6002.33万元,同比上升60.53%;其中2024年第三季度,公司单季度主营收入1.96亿元,同比上升26.85%;单季度归母净利润2736.19万元,同比上升701.72%;单季度扣非净利润1847.07万元,同比上升1075.67%;负债率13.31%,投资收益-343.89万元,财务费用-959.29万元,毛利率57.69%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800023466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907"],"gpt_icon":0},{"id":"2478558175","title":"华森制药(002907.SZ)发布前三季度业绩,净利润7457.68万元,同比增长66.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478558175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478558175?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:38","pubTimestamp":1730104715,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华森制药(002907.SZ)发布2024年三季度报告,前三季度,公司实现营业收入6.14亿元,同比增长19.21%。归属于上市公司股东的净利润7457.68万元,同比增长66.56%。归属于上市公司股东的扣除非经常性损益的净利润6002.33万元,同比增长60.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002907"],"gpt_icon":0},{"id":"2477685528","title":"华森制药(002907.SZ)控股股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2477685528","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477685528?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:18","pubTimestamp":1729509535,"startTime":"0","endTime":"0","summary":"华森制药(002907.SZ)公告,公司控股股东成都地方建筑机械化工程有限公司(简...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/7.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/7.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2477855572","title":"华森制药最新公告:控股股东成都地建计划减持不超过公司总股本的3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477855572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477855572?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:10","pubTimestamp":1729509006,"startTime":"0","endTime":"0","summary":"华森制药公告,公司控股股东成都地建计划自公告披露之日起15个交易日后的3个月内,通过集中竞价方式减持不超过公司总股本的1%,通过大宗交易方式减持不超过公司总股本的2%,合计减持不超过公司总股本的3%。减持原因是控股股东经营发展需要。成都地建承诺在锁定期届满后两年内减持价格不低于发行价,且在锁定期届满后24个月内合计减持不超过其所持公司股份总数额的10%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100025206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2477853207","title":"华森制药:控股股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2477853207","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477853207?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:04","pubTimestamp":1729508668,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2475793200","title":"华森制药最新公告:收到药品再注册批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2475793200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475793200?lang=zh_cn&edition=full","pubTime":"2024-10-16 16:43","pubTimestamp":1729068209,"startTime":"0","endTime":"0","summary":"华森制药公告,公司近日收到重庆市药监局核准签发的关于公司铝碳酸镁的《化学原料药再注册批准通知书》和曲克芦丁注射液的《药品再注册批准通知书》。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600025627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2475993504","title":"华森制药(002907.SZ)收到曲克芦丁注射液药品再注册批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2475993504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475993504?lang=zh_cn&edition=full","pubTime":"2024-10-16 15:47","pubTimestamp":1729064865,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华森制药 发布公告,公司于近日收到重庆市药品监督管理局核准签发的关于公司化学原料药铝碳酸镁的《化学原料药再注册批准通知书》和药品曲克芦丁注射液的《药品再注册批准通知书》。公告称,铝碳酸镁片为公司原料药制剂一体化品种,本次获得《化学原料药再注册批准通知书》,可以有效保障铝碳酸镁原料药的质量及供应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1194707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002907"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-10-20","address":"重庆市荣昌区工业园区","stockEarnings":[{"period":"1week","weight":-0.0007},{"period":"1month","weight":-0.008},{"period":"3month","weight":0.1429},{"period":"6month","weight":0.0022},{"period":"1year","weight":-0.2013},{"period":"ytd","weight":-0.1113}],"companyName":"重庆华森制药股份有限公司","boardCode":"AI0027","perCapita":"10544股","boardName":"医药制造业","registeredCapital":"41759万元","compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0121},{"period":"3month","weight":0.1488},{"period":"6month","weight":0.0544},{"period":"1year","weight":0.0752},{"period":"ytd","weight":0.0957}],"survey":" 重庆华森制药股份有限公司主要从事中成药、化学药的研发、生产和销售,拥有片剂、颗粒剂、胶囊剂、软胶囊剂、散剂、粉针剂、冻干粉针剂、原料药、中药提取、小容量注射剂等11条生产线。公司荣获“新中国成立70周年医药行业标杆企业”荣誉称号,2019中国医药工业100强,2018年度中国中药企业TOP100,2018年度中国医药行业成长50强,中华中医药学会科学技术奖一等奖项和荣誉,并在中国非处方药物协会举办的2019年度中国非处方药生产企业排名活动中取得第58位的佳绩。公司获得由国家工业和信息化部评为“2021年国家技术创新示范企业”、由中国合格评定国家认可委员会颁发“中国合格评定国家认可委员会试验室证书”,由中华全国工商联合会、中国人力资源和社会保障部、中华全国总工会评为“全国就业与社会保障先进民营企业”、由重庆市工商业联合会评为“重庆民营企业科技创新指数100强”及“重庆制造业民营企业100强”。","serverTime":1732644757689,"listedPrice":4.53,"stockholders":"29294人(较上一季度减少1.28%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华森制药,002907,华森制药股票,华森制药股票老虎,华森制药股票老虎国际,华森制药行情,华森制药股票行情,华森制药股价,华森制药股市,华森制药股票价格,华森制药股票交易,华森制药股票购买,华森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}